Rosenberg, E., Dufort, E., Udo, T., Wilberschied, L., Kumar, J., & Tesoriero, J. et al. (2020). Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State. JAMA. doi: 10.1001/jama.2020.8630

University of Michigan - Ann Arbor

- Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial

JAMA articles about treatment interventions of COVID-19

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. Jama, 323(18), 1824-1836.
doi:10.1001/jama.2020.6019
https://jamanetwork.com/journals/jama/fullarticle/2764727/

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)


Spinner, C. D., Gottlieb, R. L., Criner, G. J., López, J. R. A., Cattelan, A. M., Viladomiu, A. S., Ogbuagu, O., Malhotra, P., Mullane, K. M., Castagna, A., Chai, L. Y. A., Roestenberg, M., Tsang, O. T. Y., Bernasconi, E., Turnier, P. L., Chang, S.-C., SenGupta, D., Hyland, R. H., Osinusi, A. O., … Marty, F. M. (2020). Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2020.16349


Learn Before

Related